Skip to content

Ioannis Kalogirou Valtis

NPI 1023508488ActiveIndividual· Internal Medicine, Hematology & Oncology· New York, NY

Internal Medicine, Hematology & Oncology in New York, New York, trained at Harvard Medical School (class of 2018). Part D covered 23 prescriptions written in 2024, 91% of them generic. Genentech USA, Inc. reported $71.63 in payments in 2024, mostly food and beverage.

Overview

NPI1023508488
StatusActive
Entity typeIndividual
Sole proprietorNo
NPI issuedMay 11, 2018
Last updated in NPPESFeb 27, 2025
Certified by providerFeb 27, 2025

Specialties and licenses

TaxonomyCodeLicenseState
Internal Medicine, Hematology & Oncology Primary207RH0003X323055NY

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Oct 9, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 10, 2026No match—
New York OMIG · Nov 10, 2026No match—
Ohio Medicaid · Nov 10, 2026No match—
Pennsylvania Medicheck · Nov 10, 2026No match—
Washington HCA · Nov 10, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Practitioner - Hematology/Oncology (NY)

Part D prescriptions in 2024

Prescriptions (claims)23 · 23 30-day fills
Patients12
Total drug cost$1,936
Generic share91% of claims

Medicare sources and data years

Education and affiliations

Medical schoolHarvard Medical School
Graduation year2018
Medicare specialtyHematology/Oncology
TelehealthOffers telehealth

Medical groups

Source: CMS Care Compare

Industry payments (Open Payments)

  • 2024$71.63 · 1 payment from 1 company

Top paying companies in 2024

CompanyAmountPayments
Genentech USA, Inc.$71.631

What the 2024 payments were for

  • Food and Beverage$71.63 · 1 payment

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Internal Medicine, Hematology & Oncology providers in New York

All Internal Medicine, Hematology & Oncology providers in New York →